Appointments of Hongjuan Liu and Mark Czajkowski follow Manulife’s recent re-domiciliation and ongoing investment in AI and data initiatives in the region.
The Shield MCD test screens for 10 of the most common cancers — bladder, colorectal, breast, prostate, esophageal, gastric, liver, lung, ovarian, and pancreatic — with just a blood draw.
Agarwal brings nearly 30 years of experience across life and general insurance, corporate, and retail lending. He previously led the transition of Kotak General Insurance into a joint venture with Zurich...
